1. Home
  2. HOFT vs EQ Comparison

HOFT vs EQ Comparison

Compare HOFT & EQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hooker Furnishings Corporation

HOFT

Hooker Furnishings Corporation

HOLD

Current Price

$16.80

Market Cap

144.6M

ML Signal

HOLD

EQ

Equillium Inc.

HOLD

Current Price

$2.97

Market Cap

129.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HOFT
EQ
Founded
1924
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
144.6M
129.0M
IPO Year
1999
2018

Fundamental Metrics

Financial Performance
Metric
HOFT
EQ
Price
$16.80
$2.97
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$8.00
AVG Volume (30 Days)
101.7K
876.2K
Earning Date
04-16-2026
05-25-2026
Dividend Yield
3.79%
N/A
EPS Growth
N/A
N/A
EPS
0.10
N/A
Revenue
$278,139,000.00
$41,095,000.00
Revenue This Year
$17.37
N/A
Revenue Next Year
$9.00
N/A
P/E Ratio
$176.80
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.62
$0.29
52 Week High
$18.09
$3.54

Technical Indicators

Market Signals
Indicator
HOFT
EQ
Relative Strength Index (RSI) 61.72 52.86
Support Level $11.99 $1.68
Resistance Level $17.65 $3.15
Average True Range (ATR) 1.06 0.26
MACD 0.10 -0.01
Stochastic Oscillator 59.38 26.41

Price Performance

Historical Comparison
HOFT
EQ

About HOFT Hooker Furnishings Corporation

Hooker Furnishings Corp is a designer, marketer and importer of casegoods (wooden and metal furniture), leather furniture, fabric-upholstered furniture, lighting, accessories, and home decor for the residential, hospitality and contract markets. It is also domestically manufactured premium residential custom leather, custom fabric-upholstered furniture, and outdoor furniture. The company operates in four segment Hooker Branded segment, Home Meridian segment, Domestic Upholstery segment and All Other.

About EQ Equillium Inc.

Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.

Share on Social Networks: